Literature DB >> 27812536

Rasch Analysis of The WURSS-21 Dimensional Validation and Assessment of Invariance.

Roger L Brown1, Chidi N Obasi2, Bruce Barrett2.   

Abstract

BACKGROUND: The purpose of this study is to use Rasch analysis to explore the validity of considering self-report scores from Wisconsin Upper Respiratory Symptom Survey (WURSS-21) as a single global illness severity domain. The WURSS-21 is a widely used questionnaire instrument that assesses symptom severity and functional impact of common cold and flu-like illness.
METHODS: This study applies item response theory, specifically Rasch modeling, to investigate dimensional and measurement properties of the WURSS-21, and looks at invariance over time. The data assessed represents 1167 people, each scoring the WURSS-21 once daily for up to seven consecutive days of acute upper respiratory infection (URI) illness.
RESULTS: Rasch analysis supports a single domain WURSS-21 global symptom score. Assessment of differential item functioning across seven days of illness provides evidence for measurement invariance. While individual items rating physical symptoms were somewhat variable, items rating functional impairment and quality of life impact appeared quite consistent across a single domain over seven days of illness.
CONCLUSION: Rasch analysis of WURSS-21 items provides evidential support for a single invariant domain. These findings support the practice of using a simply summed daily global illness severity score to represent the overall symptomatic and functional impairments arising from URI.

Entities:  

Keywords:  Common cold; Patient reported outcomes; Quality of life; URI; Validation

Year:  2016        PMID: 27812536      PMCID: PMC5089813          DOI: 10.15406/jlprr.2015.03.00076

Source DB:  PubMed          Journal:  J Lung Pulm Respir Res        ISSN: 2376-0060


  17 in total

1.  The Wisconsin Upper Respiratory Symptom Survey (WURSS): a new research instrument for assessing the common cold.

Authors:  Bruce Barrett; Kristin Locken; Rob Maberry; Jason Schwamman; Roger Brown; Jim Bobula; Ellyn A Stauffacher
Journal:  J Fam Pract       Date:  2002-03       Impact factor: 0.493

2.  Acute respiratory diseases of viral etiology. VII. Present concepts of the common cold.

Authors:  G G JACKSON; H F DOWLING; R L MULDOON
Journal:  Am J Public Health Nations Health       Date:  1962-06

3.  Meditation or exercise for preventing acute respiratory infection: a randomized controlled trial.

Authors:  Bruce Barrett; Mary S Hayney; Daniel Muller; David Rakel; Ann Ward; Chidi N Obasi; Roger Brown; Zhengjun Zhang; Aleksandra Zgierska; James Gern; Rebecca West; Tola Ewers; Shari Barlow; Michele Gassman; Christopher L Coe
Journal:  Ann Fam Med       Date:  2012 Jul-Aug       Impact factor: 5.166

4.  The annual impact of seasonal influenza in the US: measuring disease burden and costs.

Authors:  Noelle-Angelique M Molinari; Ismael R Ortega-Sanchez; Mark L Messonnier; William W Thompson; Pascale M Wortley; Eric Weintraub; Carolyn B Bridges
Journal:  Vaccine       Date:  2007-04-20       Impact factor: 3.641

5.  Confirmatory factor analysis and item response theory: two approaches for exploring measurement invariance.

Authors:  Steven P Reise; Keith F Widaman; Robin H Pugh
Journal:  Psychol Bull       Date:  1993-11       Impact factor: 17.737

6.  The economic burden of non-influenza-related viral respiratory tract infection in the United States.

Authors:  A Mark Fendrick; Arnold S Monto; Brian Nightengale; Matthew Sarnes
Journal:  Arch Intern Med       Date:  2003-02-24

7.  Effect of vitamin D3 supplementation on upper respiratory tract infections in healthy adults: the VIDARIS randomized controlled trial.

Authors:  David R Murdoch; Sandy Slow; Stephen T Chambers; Lance C Jennings; Alistair W Stewart; Patricia C Priest; Christopher M Florkowski; John H Livesey; Carlos A Camargo; Robert Scragg
Journal:  JAMA       Date:  2012-10-03       Impact factor: 56.272

8.  Quercetin supplementation and upper respiratory tract infection: A randomized community clinical trial.

Authors:  Serena A Heinz; Dru A Henson; Melanie D Austin; Fuxia Jin; David C Nieman
Journal:  Pharmacol Res       Date:  2010-05-15       Impact factor: 7.658

9.  The Wisconsin Upper Respiratory Symptom Survey is responsive, reliable, and valid.

Authors:  Bruce Barrett; Roger Brown; Marlon Mundt; Nasia Safdar; Leota Dye; Rob Maberry; Jennifer Alt
Journal:  J Clin Epidemiol       Date:  2005-06       Impact factor: 6.437

10.  Validation of a short form Wisconsin Upper Respiratory Symptom Survey (WURSS-21).

Authors:  Bruce Barrett; Roger L Brown; Marlon P Mundt; Gay R Thomas; Shari K Barlow; Alex D Highstrom; Mozhdeh Bahrainian
Journal:  Health Qual Life Outcomes       Date:  2009-08-12       Impact factor: 3.186

View more
  2 in total

1.  Meditation or exercise for preventing acute respiratory infection (MEPARI-2): A randomized controlled trial.

Authors:  Bruce Barrett; Mary S Hayney; Daniel Muller; David Rakel; Roger Brown; Aleksandra E Zgierska; Shari Barlow; Supriya Hayer; Jodi H Barnet; Elisa R Torres; Christopher L Coe
Journal:  PLoS One       Date:  2018-06-22       Impact factor: 3.240

2.  The Development of Instrument to Assess Physician's Practice in the Management of Patients With Terminal Diseases.

Authors:  Nita Arisanti; Elsa Pudji Setiawati Sasongko; Veranita Pandia; Dany Hilmanto
Journal:  J Prim Care Community Health       Date:  2020 Jan-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.